BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rosemann M, Kuosaite V, Kremer M, Favor J, Quintanilla-martinez L, Atkinson MJ. Multilocus inheritance determines predisposition to α-radiation induced bone tumourigenesis in mice. Int J Cancer 2006;118:2132-8. [DOI: 10.1002/ijc.21612] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Gonzalez-Vasconcellos I, Domke T, Kuosaite V, Esposito I, Sanli-Bonazzi B, Nathrath M, Atkinson MJ, Rosemann M. Differential effects of genes of the Rb1 signalling pathway on osteosarcoma incidence and latency in alpha-particle irradiated mice. Radiat Environ Biophys 2011;50:135-41. [PMID: 21063720 DOI: 10.1007/s00411-010-0339-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
2 Heidenreich WF, Rosemann M. Genetic background and 227Thorium as risk factors in biologically based models for induction of bone cancer in mice. Radiat Environ Biophys 2012;51:179-85. [DOI: 10.1007/s00411-012-0409-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Koltes JE, Kumar D, Kataria RS, Cooper V, Reecy JM. Transcriptional profiling of PRKG2-null growth plate identifies putative down-stream targets of PRKG2. BMC Res Notes 2015;8:177. [PMID: 25924610 DOI: 10.1186/s13104-015-1136-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
4 Daino K, Ugolin N, Altmeyer-morel S, Guilly M, Chevillard S. Gene expression profiling of alpha-radiation-induced rat osteosarcomas: Identification of dysregulated genes involved in radiation-induced tumorigenesis of bone. Int J Cancer 2009;125:612-20. [DOI: 10.1002/ijc.24392] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
5 Mullenders L, Atkinson M, Paretzke H, Sabatier L, Bouffler S. Assessing cancer risks of low-dose radiation. Nat Rev Cancer 2009;9:596-604. [DOI: 10.1038/nrc2677] [Cited by in Crossref: 143] [Cited by in F6Publishing: 115] [Article Influence: 11.0] [Reference Citation Analysis]
6 Rosemann M, Gonzalez-Vasconcellos I, Domke T, Kuosaite V, Schneider R, Kremer M, Favor J, Nathrath M, Atkinson MJ. A Rb1 promoter variant with reduced activity contributes to osteosarcoma susceptibility in irradiated mice. Mol Cancer 2014;13:182. [PMID: 25092376 DOI: 10.1186/1476-4598-13-182] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
7 Newhauser WD, Durante M. Assessing the risk of second malignancies after modern radiotherapy. Nat Rev Cancer 2011;11:438-48. [PMID: 21593785 DOI: 10.1038/nrc3069] [Cited by in Crossref: 256] [Cited by in F6Publishing: 197] [Article Influence: 23.3] [Reference Citation Analysis]
8 Fujiwara T, Fujiwara M, Numoto K, Ogura K, Yoshida A, Yonemoto T, Suzuki S, Kawai A. Second primary osteosarcomas in patients with retinoblastoma. Jpn J Clin Oncol 2015;45:1139-45. [PMID: 26438540 DOI: 10.1093/jjco/hyv140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]